Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 5.1 Opinion of Goodwin Procter LLP As to the Validity of the Securities Being Registered
- 10.4 Form of Indemnification Agreement by and Between Phoenix Biotech Acquisition Corp. and Each of Its Directors and Executive Officers, to Be Effective on or after the Closing of the Business Combination
- 23.1 Consent of Wolf & Company P.C., Independent Registered Public Accounting Firm
- 23.1 Consent of Citrin Cooperman & Company LLP, Independent Registered Public Accounting Firm
- 99.2 Consent of Rna Advisors, LLC
- Download Excel data file
- View Excel data file
Associated filings
- 6 Feb 24 424B3 Prospectus supplement
- 22 Jan 24 424B3 Prospectus supplement
- 22 Jan 24 EFFECT Notice of effectiveness
- 16 Jan 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 8 Jan 24 S-4/A Registration of securities issued in business combination transactions (amended)
-
15 Dec 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 11 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 19 Jul 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 6 Jun 23 S-4 Registration of securities issued in business combination transactions
CERO similar filings
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-4 of our report dated March 22, 2023, relating to the financial statements of Phoenix Biotech Acquisition Corp. as of December 31, 2022 and 2021 and for the year ended December 31, 2022 and the period from June 8, 2021 (Inception) to December 31, 2021. Our report contains an explanatory paragraph regarding substantial doubt about the Company’s ability to continue as a going concern. We also consent to the use of our name as it appears under the caption “Experts” in this Registration Statement.
/s/ CITRIN COOPERMAN & COMPANY, LLP
New York, New York
December 15, 2023